TG Therapeutics Inc TGTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 03/27/24 EDT
15.57quote price arrow up+0.13 (+0.84%)
Volume
1,348,421
52 week range
6.46 - 35.67
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close15.57
  • 52 Week High35.67
  • 52 Week High Date05/04/23
  • 52 Week Low6.46
  • 52 Week Low Date10/16/23

Key Stats

  • Market Cap2.404B
  • Shares Out154.42M
  • 10 Day Average Volume2.50M
  • Dividend-
  • Dividend Yield-
  • Beta2.30
  • YTD % Change-8.84

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close15.57
  • 52 Week High35.67
  • 52 Week High Date05/04/23
  • 52 Week Low6.46
  • 52 Week Low Date10/16/23
  • Market Cap2.404B
  • Shares Out154.42M
  • 10 Day Average Volume2.50M
  • Dividend-
  • Dividend Yield-
  • Beta2.30
  • YTD % Change-8.84

RATIOS/PROFITABILITY

  • EPS (TTM)0.01
  • P/E (TTM)1,104.26
  • Fwd P/E (NTM)-60.82
  • EBITDA (TTM)20.844M
  • ROE (TTM)11.57%
  • Revenue (TTM)233.663M
  • Gross Margin (TTM)93.95%
  • Net Margin (TTM)5.42%
  • Debt To Equity (MRQ)62.38%

EVENTS

  • Earnings Date04/29/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On TG Therapeutics Inc

 

Profile

MORE
TG Therapeutics, Inc. is a fully integrated, commercial stage, biopharmaceutical company. The Company is focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. Its clinical drug candidates include Ublituximab (anti-CD20 mAb), TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb). BRIUMVI is an anti-CD20 monoclonal antibody for the treatment of RMS, which include clinically isolated syndrome, relapsing-remitting...
Michael Weiss J.D.
Chairman of the Board, President, Chief Executive Officer
Sean Power
Chief Financial Officer, Treasurer, Corporate Secretary
Address
3020 Carrington Mill Blvd., Suite 475
Morrisville, NC
27560-5435
United States

Top Peers

SYMBOLLASTCHG%CHG
VCEL
Vericel Corp
52.33+2.77+5.59%
MOR
MorphoSys AG
18.14-0.04-0.22%
DNA
Ginkgo Bioworks
1.10+0.03+2.80%
TWST
Twist Bioscience Corp
34.48+0.73+2.16%
IMCR
Immunocore Holdings PLC
63.58+1.92+3.11%